Evidence map›Paper›PMID 22992065›Full record

ArticleTissue engineering. Part C, Methods2013

Tissue-engineered constructs of human oral mucosa examined by Raman spectroscopy.

Alexander Khmaladze, Arindam Ganguly, Shiuhyang Kuo, Mekhala Raghavan, Raghu Kainkaryam, Jacqueline H Cole, Kenji Izumi, Cynthia L Marcelo, Stephen E Feinberg, Michael D Morris

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part C, Methods, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Vascularization strategies in tissue engineering approaches for soft tissue repair.Journal of tissue engineering and regenerative medicine · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Soft tissue engineering in craniomaxillofacial surgery.Annals of maxillofacial surgery · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Alexander KhmaladzeDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
Arindam Ganguly
Shiuhyang Kuo
Mekhala Raghavan
Raghu Kainkaryam
Jacqueline H Cole
Kenji Izumi
Cynthia L Marcelo
Stephen E Feinberg
Michael D Morris
University of Michigan–Ann Arbor · USNiigata University · JP

Funding

Non-invasive Assessment of Tissue Engineered Human Oral MucosaR01DE019431 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FEINBERG, STEPHEN ELLIOTT, MYCEK, MARY-ANN · 2009 to 2012
$3.0M
NIDCR NIH HHS R01 DE019431NIDCR NIH HHS R01 DE019431-01
6 · The paper itself

Abstract

A noninvasive quality monitoring of tissue-engineered constructs is a required component of any successful tissue-engineering technique. During a 2-week production period, ex vivo produced oral mucosa-equivalent constructs (EVPOMEs) may encounter adverse culturing conditions that might compromise their quality and render them ineffective. We demonstrate the application of near-infrared Raman spectroscopy to in vitro monitoring of EVPOMEs during their manufacturing process, with the ultimate goal of applying this technology in situ to monitor the grafted EVPOMEs. We identify Raman spectroscopic failure indicators for less-than optimal EVPOMEs that are stressed by higher temperature and exposure to higher than normal concentration of calcium ions. Raman spectra of EVPOMEs exposed to thermal and calcium stress showed correlation of the band height ratio of CH(2) deformation to phenylalanine ring breathing modes, providing a Raman metric to distinguish between viable and nonviable constructs. We compared these results to histology and glucose consumption measurements, demonstrating that Raman spectroscopy is more sensitive and specific to changes in proteins' secondary structure not visible by H&E histology. We also exposed the EVPOMEs to rapamycin, a cell growth inhibitor and cell proliferation capacity preserver, and distinguished between EVPOMEs pretreated with 2 nM rapamycin and controls, using the ratio of the Amide III envelope to the phenylalanine band as an indicator.

Indexed as

Mouth MucosaTissue EngineeringCalciumGlucoseHumansSirolimusSpectrum Analysis, RamanCalciumGlucoseSirolimus

Identifiers

PMID22992065
PMCPMC3583251
OpenAlexW1999516296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.